Skip to Content

GSI 7916 (Epclusa sofosbuvir 400 mg / velpatasvir 100 mg)

Generic Name: sofosbuvir/velpatasvir

Pill with imprint GSI 7916 is Pink, Four-sided and has been identified as Epclusa sofosbuvir 400 mg / velpatasvir 100 mg. It is supplied by Gilead Sciences, Inc..

Epclusa is used in the treatment of hepatitis c and belongs to the drug class antiviral combinations. Epclusa sofosbuvir 400 mg / velpatasvir 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GSI 7916

Epclusa sofosbuvir 400 mg / velpatasvir 100 mg GSI 7916
Epclusa sofosbuvir 400 mg / velpatasvir 100 mg GSI 7916
Epclusa sofosbuvir 400 mg / velpatasvir 100 mg GSI 7916

Epclusa

Generic Name:
sofosbuvir/velpatasvir
Imprint:
GSI 7916
Strength:
sofosbuvir 400 mg / velpatasvir 100 mg
Color:
Pink
Shape:
Four-sided
Availability:
Prescription only
Drug Class:
Antiviral combinations
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Gilead Sciences, Inc.
National Drug Code (NDC):
61958-2201

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide